Viewing StudyNCT04085523



Ignite Creation Date: 2024-05-06 @ 1:40 PM
Last Modification Date: 2024-10-26 @ 1:17 PM
Study NCT ID: NCT04085523
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-07
First Post: 2019-09-09

Brief Title: A Dose Escalation Trial Evaluating Safety Efficacy and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia
Sponsor: Ascendis Pharma AS
Organization: Ascendis Pharma AS

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-24
Start Date Type: ACTUAL
Primary Completion Date: 2022-09-27
Primary Completion Date Type: ACTUAL
Completion Date: 2024-09
Completion Date Type: ESTIMATED
First Submit Date: 2019-09-09
First Submit QC Date: September 9 2019
Study First Post Date: 2019-09-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2024-03-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-12
Last Update Post Date: 2024-03-07
Last Update Post Date Type: ACTUAL